000			01560 a2200457 4500
005			20250513232522.0
264		0	_c20010510
008			200105s 0 0 eng d
022			_a0021-9150
024	7		_a10.1016/s0021-9150(00)00556-6 _2doi
040			_aNLM _beng _cNLM
100	1		_aBoemi, M
245	0	0	_aSerum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation. _h[electronic resource]
260			_bAtherosclerosis _cMar 2001
300			_a229-35 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAlleles
650	0	4	_aAntioxidants _xmetabolism
650	0	4	_aApolipoproteins B _xblood
650	0	4	_aAryldialkylphosphatase
650	0	4	_aCholesterol, LDL _xblood
650	0	4	_aDiabetes Mellitus, Type 1 _xgenetics
650	0	4	_aEsterases _xblood
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHumans
650	0	4	_aLipoproteins, HDL _xmetabolism
650	0	4	_aLipoproteins, LDL _xmetabolism
650	0	4	_aMale
650	0	4	_aOxidation-Reduction
650	0	4	_aPolymorphism, Genetic
650	0	4	_aPromoter Regions, Genetic _xgenetics
700	1		_aLeviev, I
700	1		_aSirolla, C
700	1		_aPieri, C
700	1		_aMarra, M
700	1		_aJames, R W
773	0		_tAtherosclerosis _gvol. 155 _gno. 1 _gp. 229-35
856	4	0	_uhttps://doi.org/10.1016/s0021-9150(00)00556-6 _zAvailable from publisher's website
999			_c11161282 _d11161282